The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method

被引:100
作者
Coombes, AGA [1 ]
Yeh, MK [1 ]
Lavelle, EC [1 ]
Davis, SS [1 ]
机构
[1] Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England
基金
英国医学研究理事会;
关键词
poly(lactide-co-glycolide); controlled-release; protein; vaccine biodegradable; microparticles; polyvinylpyrrolidone;
D O I
10.1016/S0168-3659(98)00006-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(DL-lactide co-glycolide) microparticles below 5 mu m in size and containing ovalbumin (OVA), were prepared using the water-in oil-in water (w/o/w) technique with either polyvinyl alcohol (PVA) or polyvinylpyrrolidone (PVP) as stabilisers in the external aqueous phase. PVP-stabilised microparticles exhibited higher protein loading (8.2%, w/w relative to 4.0% for PVA stabilised microparticles) and increased core loading (encapsulation) of protein (70% vs. 30% for the PVA system). The use of PVP instead of PVA to prepare microparticles also resulted in reduction in the initial burst release of OVA, together with sustained protein release over 28 days and an increase in the protein delivery capacity from 35 to 45 mu g/mg particles. The changes in protein loading and delivery characteristics are considered to arise in part from an increase in the viscosity of the droplets of polymer solution, constituting the primary water-in oil emulsion, by diffusion of PVP from the external aqueous phase. Variation of the external aqueous phase surfactant provides a promising approach for improving the loading of therapeutic proteins and vaccine antigens within biodegradable microparticles and for modulating their release pattern. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:311 / 320
页数:10
相关论文
共 27 条
  • [1] CONTROLLED-RELEASE VACCINES - BIODEGRADABLE POLYLACTIDE POLYGLYCOLIDE (PL/PG) MICROSPHERES AS ANTIGEN VEHICLES
    AGUADO, MT
    LAMBERT, PH
    [J]. IMMUNOBIOLOGY, 1992, 184 (2-3) : 113 - 125
  • [2] DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES
    ALONSO, MJ
    COHEN, S
    PARK, TG
    GUPTA, RK
    SIBER, GR
    LANGER, R
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (07) : 945 - 953
  • [3] Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method
    BlancoPrieto, MJ
    Leo, E
    Delie, F
    Gulik, A
    Couvreur, P
    Fattal, E
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (07) : 1127 - 1129
  • [4] SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD
    BODMEIER, R
    MCGINITY, JW
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) : 179 - 186
  • [5] Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: Effects of polymer molecular weight and surface properties
    Boury, F
    Marchais, H
    Proust, JE
    Benoit, JP
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) : 75 - 86
  • [6] CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES
    COHEN, S
    YOSHIOKA, T
    LUCARELLI, M
    HWANG, LH
    LANGER, R
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (06) : 713 - 720
  • [7] CONWAY BR, 1994, P INT S CONTR REL BI, V21, P284
  • [8] Single dose, polymeric, microparticle based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen
    Coombes, AGA
    Lavelle, EC
    Jenkins, PG
    Davis, SS
    [J]. VACCINE, 1996, 14 (15) : 1429 - 1438
  • [9] BIODEGRADABLE POLYMERS FOR PROTEIN AND PEPTIDE DRUG-DELIVERY
    GOMBOTZ, WR
    PETTIT, DK
    [J]. BIOCONJUGATE CHEMISTRY, 1995, 6 (04) : 332 - 351
  • [10] RELEASE OF HUMAN SERUM-ALBUMIN FROM POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES
    HORA, MS
    RANA, RK
    NUNBERG, JH
    TICE, TR
    GILLEY, RM
    HUDSON, ME
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (11) : 1190 - 1194